Aster DM Healthcare has received approval from the National Company Law Tribunal (NCLT), Hyderabad Bench, to convene meetings of its shareholders and unsecured trade creditors to seek approval for its proposed merger with Quality Care India Limited (QCIL).
The meetings will be held between February 27 and March 13, 2026. The merger has already secured clearance from the Competition Commission of India (CCI) and received no-objection letters from the stock exchanges.
Subject to approvals from shareholders, creditors and remaining regulatory authorities, Aster DM Healthcare expects to complete the merger by the first quarter of FY2026–27.
The combined platform will integrate four established healthcare brands: Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare.
As of September 30, 2025, the combined bed capacity of Aster and QCIL exceeds 10,360 beds, with Aster operating over 5,195 beds and QCIL operating 5,165 beds across India. The merged entity has outlined plans to expand its capacity to approximately 14,715 beds in the coming years.
Also Read